Theranos

Good-Bye to Theranos

Blood-testing firm Theranos is to shutter, the Wall Street Journal reports.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Still Going for Small

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

The US Securities and Exchange Commission charged Elizabeth Holmes, the founder and CEO of Theranos, with fraud.

The Wall Street Journal reports that the erstwhile partners have reached a settlement of more than $25 million.

Asking for the Data

Biotech investors are learning from their mistakes following the Theranos fiasco, according to Wired.

Theranos Settles

The embattled firm has reached deals with both the Centers for Medicare & Medicaid Services and Arizona.

Elizabeth Holmes, the founder of Theranos, owes the firm millions, the Wall Street Journal reports.

'Repeated Violations'

A federal inspection report obtained by the Wall Street Journal describes deficiencies at Theranos' Arizona lab.

Second Failure

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.

Pages

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.